Updates are available Correction dated 2025-02-18

Article History

Received: 26 October 2022

Accepted: 22 February 2023

First Online: 19 April 2023

Change Date: 20 February 2025

Change Type: Update

Change Details: The original online version of this article was revised: the authors noticed an error in Abstract result section and Discussion section on page 8, and requested to change the email address of the corresponding author from “ying.kong@roche.com” to “kongyingsfy@gmail.com”.

Change Date: 18 February 2025

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1186/s13000-025-01605-6

Declarations

:

: Institutional review board approval was obtained by the Roche Tissue Diagnostics Clinical Operation Department. The two reader precision studies used commercial samples. For the samples used in the comparison study, which were collected as part of a BeiGene study, consent was obtained in compliance with requirements.

: Not applicable.

: CL and FF were employees of Roche Tissue Diagnostics at the time of the study. YK is an employee of Roche Tissue Diagnostics. EAE is Chief Medical Officer of Akoya Biosciences Inc. and was an employee of Roche Tissue Diagnostics at the time of the study.